Showing results (1261-1270 of 3,159) with videos related to

Sort By:
Pageof 316
Swiss Medical Weekly|July 4, 2013
Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in SwitzerlandWaldemar Greil, Anne Häberle, Thomas Schuhmann, et al.
Swiss Medical Weekly|July 24, 2014
Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre studyBernhard Gerber, Jan Köppel, Michaela Paul, et al.
Swiss Medical Weekly|December 5, 2013
Perception of preference and risk-taking in laparoscopy, transgastric, and rigid-hybrid transvaginal NOTES for cholecystectomyMichael C Sulz, Andreas Zerz, Markus Sagmeister, et al.
Swiss Medical Weekly|December 5, 2013
The new licencing examination for human medicine: from concept to implementationSissel Guttormsen, Christine Beyeler, Raphael Bonvin, et al.
Swiss Medical Weekly|August 30, 2013
Novel therapeutic options in inflammatory cardiomyopathyGabriela Kania, Przemyslaw Blyszczuk, Björn Müller-Edenborn, et al.
Swiss Medical Weekly|August 30, 2013
Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipientsSheng-Wen Wu, Hui-Ching Tsai, Pao-Yu Tsai, et al.
Swiss Medical Weekly|September 11, 2013
Exploratory survey about dietary supplement use: a hazardous and erratic way to improve one's health?David S Troxler, Pierre-André Michaud, Bertrand Graz, et al.
Swiss Medical Weekly|September 11, 2013
The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysisWeiwei Ren, Denghai Mi, Kehu Yang, et al.
Swiss Medical Weekly|December 25, 2015
Death certificate notifications in the Swiss Childhood Cancer Registry: assessing completeness and registration proceduresMatthias Schindler, Vera Mitter, Eva Bergstraesser, et al.
Swiss Medical Weekly|January 15, 2016
Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds--an optical coherence tomography substudy of the EVERBIO II trialZacharenia Kallinikou, Diego Arroyo, Mario Togni, et al.
Pageof 316